BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24090823)

  • 1. Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models.
    Moore H; Geyer MA; Carter CS; Barch DM
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2087-91. PubMed ID: 24090823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting.
    Barch DM; Carter CS; Arnsten A; Buchanan RW; Cohen JD; Geyer M; Green MF; Krystal JH; Nuechterlein K; Robbins T; Silverstein S; Smith EE; Strauss M; Wykes T; Heinssen R
    Schizophr Bull; 2009 Jan; 35(1):109-14. PubMed ID: 19023126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNTRICS final task selection: control of attention.
    Nuechterlein KH; Luck SJ; Lustig C; Sarter M
    Schizophr Bull; 2009 Jan; 35(1):182-96. PubMed ID: 19074499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery research.
    Gilmour G; Arguello A; Bari A; Brown VJ; Carter C; Floresco SB; Jentsch DJ; Tait DS; Young JW; Robbins TW
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2125-40. PubMed ID: 22548905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing long-term memory in animal models of schizophrenia: suggestions from CNTRICS.
    Bussey TJ; Barch DM; Baxter MG
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2141-8. PubMed ID: 23792049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.
    Carter CS; Barch DM
    Schizophr Bull; 2007 Sep; 33(5):1131-7. PubMed ID: 17630405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNTRICS final animal model task selection: control of attention.
    Lustig C; Kozak R; Sarter M; Young JW; Robbins TW
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2099-110. PubMed ID: 22683929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNTRICS final task selection: working memory.
    Barch DM; Berman MG; Engle R; Jones JH; Jonides J; Macdonald A; Nee DE; Redick TS; Sponheim SR
    Schizophr Bull; 2009 Jan; 35(1):136-52. PubMed ID: 18990711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive [Computational] Neuroscience Test Reliability and Clinical Applications for Serious Mental Illness (CNTRaCS) Consortium: Progress and Future Directions.
    Barch DM; Boudewyn MA; Carter CC; Erickson M; Frank MJ; Gold JM; Luck SJ; MacDonald AW; Ragland JD; Ranganath C; Silverstein SM; Yonelinas A
    Curr Top Behav Neurosci; 2023; 63():19-60. PubMed ID: 36173600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models and measures of perceptual processing in schizophrenia.
    Siegel SJ; Talpos JC; Geyer MA
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2092-8. PubMed ID: 23867801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: the CNTRICS initiative.
    Millan MJ; Bales KL
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2166-80. PubMed ID: 24090822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNTRICS imaging biomarkers final task selection: Long-term memory and reinforcement learning.
    Ragland JD; Cohen NJ; Cools R; Frank MJ; Hannula DE; Ranganath C
    Schizophr Bull; 2012 Jan; 38(1):62-72. PubMed ID: 22102094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNTRICS final task selection: social cognitive and affective neuroscience-based measures.
    Carter CS; Barch DM; Gur R; Gur R; Pinkham A; Ochsner K
    Schizophr Bull; 2009 Jan; 35(1):153-62. PubMed ID: 19011231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNTRICS final task selection: executive control.
    Barch DM; Braver TS; Carter CS; Poldrack RA; Robbins TW
    Schizophr Bull; 2009 Jan; 35(1):115-35. PubMed ID: 19011235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNTRICS imaging biomarkers selection: Working memory.
    Barch DM; Moore H; Nee DE; Manoach DS; Luck SJ
    Schizophr Bull; 2012 Jan; 38(1):43-52. PubMed ID: 22080498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders.
    Carter CS; Barch DM; Bullmore E; Breiling J; Buchanan RW; Butler P; Cohen JD; Geyer M; Gollub R; Green MF; Jaeger J; Krystal JH; Moore H; Nuechterlein K; Robbins T; Silverstein S; Smith EE; Strauss M; Wykes T
    Biol Psychiatry; 2011 Jul; 70(1):7-12. PubMed ID: 21529781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative.
    Barch DM; Carter CS;
    Schizophr Bull; 2008 Jul; 34(4):613-8. PubMed ID: 18499705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia.
    Barch DM; Smith E
    Biol Psychiatry; 2008 Jul; 64(1):11-7. PubMed ID: 18400207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative.
    Carter CS; Barch DM; Buchanan RW; Bullmore E; Krystal JH; Cohen J; Geyer M; Green M; Nuechterlein KH; Robbins T; Silverstein S; Smith EE; Strauss M; Wykes T; Heinssen R
    Biol Psychiatry; 2008 Jul; 64(1):4-10. PubMed ID: 18466880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference.
    Nuechterlein KH; Robbins TW; Einat H
    Schizophr Bull; 2005 Oct; 31(4):870-4. PubMed ID: 16150960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.